Zogenix, Inc.

( )
ZGNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc 5.00%5.041.6%$114.23m
VRXValeant Pharmaceuticals International, Inc. 1.51%14.8414.1%$87.32m
PRGOPerrigo Co. Plc -1.11%47.046.8%$83.86m
JAZZJazz Pharmaceuticals Plc -0.52%105.222.3%$81.91m
CTLTCatalent, Inc. 0.53%52.672.2%$74.40m
ICLRICON plc -0.74%144.004.2%$71.51m
UTHRUnited Therapeutics Corp. -0.73%95.0614.3%$71.27m
HZNPHorizon Therapeutics Plc -3.76%30.766.5%$70.40m
AXSMAxsome Therapeutics, Inc. -6.87%49.871.9%$61.04m
GWPHGW Pharmaceuticals Plc 5.94%91.726.2%$57.93m
ICPTIntercept Pharmaceuticals, Inc. 0.10%62.9116.8%$42.33m
SAGESAGE Therapeutics, Inc. 2.33%29.038.6%$41.08m
PBHPrestige Consumer Healthcare, Inc. -1.89%38.434.0%$34.26m
PCRXPacira Biosciences, Inc. 1.97%32.6310.4%$30.74m
MYOKMyoKardia, Inc. -1.79%47.192.1%$25.98m

Company Profile

Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.